earticle

논문검색

Abstracts for poster Presentation

O-GlcNAc modification of Mef2c regulates C2C12 myoblast differentiation

초록

영어

O-GlcNAc modification is glycosylation that occurs on Serine and Threonine residues of proteins located in nucleus and cytoplasm. O-GlcNAcylation regulates various cellular events including transcription, translation, cell death and cell proliferation as cellular nutrient sensor. It also has important roles in development processes such as neurogenesis, osteogenesis, adipogenesis and myogenesis. Although some roles and molecular mechanism of O-GlcNAcylation in various development process has been studied, the relationship between O-GlcNAcylation and muscle differentiation is not clearly established. We confirm that physiological conditions to regulate cellular O-GlcNAc level as well as O-GlcNAcase inhibitor treatment influenced the myogenin expression and myogenesis. We also confirm that this results was shown in mouse model system. We demonstrate that these phenomenons result from O-GlcNAc of Mef2c. Furthermore, we identify the 3 O-GlcNAc sites in Mef2c and find that one of these site has role regulating the DNA binding affinity with promoter of myogenin. Our results suggest that one specific O-GlcNAc site of Mef2c is closely associated with muscle differentiation through the regulation of myogenin transcription.

저자정보

  • Han Byeol Kim Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University
  • Jung Hwa Seo Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University
  • Hyun Gyu Seo Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University
  • Hyeonjin Choi Functional Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)
  • Byung Gyu Kim Leading-edge Research Center for Drug Discovery and Development and Metabolic Disease, Kyungpook National University, Daegu, Korea
  • Sang Yoon Park Cell Biology and Metabolism Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892
  • Sunghoon Kim Medicinal Bioconvergence Research Center Department of Molecular Medicine and Biopharmaceutical Sciences Graduate School of Convergence Science and Technology College of Pharmacy, Seoul National University.
  • Jaeyoung Pai Department of Chemistry, Yonsei University
  • Injae Shin Department of Chemistry, Yonsei University
  • Jin Won Cho Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.